| 0 |
Cannabinoid [EPC] |
1 |
0.0001 |
| 1 |
CD52-directed Cytolytic Antibody [EPC] |
2 |
0.0001 |
| 2 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
1 |
0.0001 |
| 3 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
7 |
0.0001 |
| 4 |
Aminoglycoside Antibacterial [EPC] |
2 |
0.0000 |
| 5 |
Histamine-1 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 6 |
Nucleoside Analog Antiviral [EPC] |
2 |
0.0000 |
| 7 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
2 |
0.0000 |
| 8 |
Dihydropyridine Calcium Channel Blocker [EPC] |
7 |
0.0000 |
| 9 |
Xanthine Oxidase Inhibitor [EPC] |
3 |
0.0000 |
| 10 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 13 |
Osmotic Laxative [EPC] |
3 |
0.0000 |
| 14 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 15 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 16 |
Vitamin D [EPC] |
3 |
0.0000 |
| 17 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 18 |
Benzodiazepine [EPC] |
6 |
0.0000 |
| 19 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 20 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 22 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 23 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 24 |
Vitamin C [EPC] |
3 |
0.0000 |
| 25 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 26 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 27 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 28 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 31 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 32 |
Loop Diuretic [EPC] |
1 |
0.0000 |
| 33 |
Tumor Necrosis Factor Blocker [EPC] |
2 |
0.0000 |
| 34 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 35 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2 |
0.0000 |